DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Hilton Arlington Towers

2022年9月20日 (火) 午前 7:00 - 2022年9月21日 (水) 午後 3:00

950 N Stafford St., Arlington, VA 22203-1813, USA

Biosimilars Conference

Convening Professionals in Biosimilar Development to Discuss the Challenges of Today and the Possibilities of Tomorrow

SPONSORED SESSION: Case Study Spotlight hosted by Similis Bio: A Distributed Innovator Data Collection Approach to Expedite Biosimilar Development

Session Chair(s)

Brad  Prater

Brad Prater

Director, Product and Process Development

Similis Bio, United States

*This course requires a Separate RSVP.

Case Study Spotlight hosted by Similis Bio: A Distributed Innovator Data Collection Approach to Expedite Biosimilar Development

In contrast to developing a new biological entity where mechanism of action and clinical efficacy are leading indicators of long-term success, development of a biosimilar relies heavily on analytical characterization of both the innovator and biosimilar products. Regulatory guidance on carrying out similarity or comparability studies has recommended carrying out all testing of product lots side by side to minimize variability and increase the robustness of the data set. In this talk, a novel lifecycle approach to generating comprehensive data sets for both functional and physiochemical methods will be presented, relying on continuous sourcing of innovator material early and often in the product’s lifecycle. By using data sets generated across a wide time scale, the true variation in both the innovator and biosimilar quality attributes can be determined resulting in appropriate specification setting for production. Case studies will be presented for biosimilar products under development.

Featured Topics:
  • Biosimilar Development
  • Risk Based Approached
  • Analytics Characterization
  • Data Science
  • Click here to RSVP!



最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。